Concepedia

Helen Ye

HY

Statistics

Publications

6

Citations

540

H-Index

6

Active since

2000

Affiliations

Itron (United States)(Current)

Helen Ye is an author at Itron (United States) specializing in oncology, molecular oncology, and pharmacology.

Publications per year

2000–2008

6

Publications

6

<i>In vivo</i> Target Modulation and Biological Activity of CHIR-258, a Multitargeted Growth Factor Receptor Kinase Inhibitor, in Colon Cancer Models

Sang Hoon Lee, Daniel L. Menezes, Jayesh Vora et al. · Clinical Cancer Research · 2005 · 173 citations

, , +17

Design, Structure−Activity Relationships and in Vivo Characterization of 4-Amino-3-benzimidazol-2-ylhydroquinolin-2-ones: A Novel Class of Receptor Tyrosine Kinase Inhibitors

Paul A. Renhowe, Sabina Pecchi, Cynthia M. Shafer et al. · Journal of Medicinal Chemistry · 2008 · 135 citations · Full text

, , +13

CHIR-258: A Potent Inhibitor of FLT3 Kinase in Experimental Tumor Xenograft Models of Human Acute Myelogenous Leukemia

Daniel E. Lopes de Menezes, Jing Peng, Evelyn N. Garrett et al. · Clinical Cancer Research · 2005 · 112 citations · Full text

, , +16

Distribution of ion transport mRNAs throughout murine nose and lung

Lori G. Rochelle, Dong Chen Li, Helen Ye et al. · American Journal of Physiology-Lung Cellular and Molecular Physiology · 2000 · 78 citations · Full text

, , +17

Recombinant Interleukin-2 Significantly Augments Activity of Rituximab in Human Tumor Xenograft Models of B-cell Non-Hodgkin Lymphoma

Daniel E. Lopes de Menezes, Kimberly Denis-Mize, Yan Tang et al. · Journal of Immunotherapy · 2006 · 28 citations

, , +17

1–5 of 6